News | January 11, 2026
PAI Pharma acquires Nivagen to boost US injectable drug production
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The new facility is expected to generate 500-600 new jobs in the region
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
